Identification of a PTH regulated gene selectively induced in vivo during PTH-mediated bone formation

Journal of Cellular Biochemistry

Volumn 98, Issue 5, 2006, Pages 1203-1220

  Robinson, John A ^a   Susulic, Vedrana ^a,b   Liu, Yao Bin ^a   Taylor, Chanda ^a   Hardenburg, Jill ^a   Gironda, Virginia ^a   Zhao, Weiguang ^a,c   Kharode, Yogendra ^a   McLarney, Sean ^a   Bai, Yuchen ^a   Malone, Daniel P ^a   Murrills, Richard ^a   Bex, Fred ^a  

^a PFIZER INC   (United States)

^b CENTOCOR INC   (United States)

^c SANOFI   (France)

Author keywords

BAALC; Bone anabolic; Bone mineral density; Osteoblast; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; ANABOLIC AGENT; BIOLOGICAL MARKER; CALCITRIOL; OSTEOCALCIN; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34];

ACUTE LEUKEMIA; ANIMAL CELL; ARTICLE; BONE CELL; BONE DENSITY; BONE MINERAL; BONE REMODELING; CELL FUNCTION; COMPLEX FORMATION; GENE IDENTIFICATION; GENETIC REGULATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL MARKERS; CALCITRIOL; CELL DIFFERENTIATION; CELLS, CULTURED; CONSERVED SEQUENCE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; OSTEOBLASTS; OSTEOGENESIS; PARATHYROID HORMONE; RATS; RATS, SPRAGUE-DAWLEY; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

EID: 33746413795     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20822     Document Type: Article

References (59)

1. Abou-Samra AB, Juppner H, Force T, Freeman MW, Kong XF, Schipani E, Urena P, Richards J, Bonventre JV, Potts JT, Jr., et al. 1992. Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: A single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc Natl Acad Sci USA 89:2732-2736.
2. Adams AE, Rosenblatt M, Suva LJ. 1999. Identification of a novel parathyroid hormone-responsive gene in human osteoblastic cells. Bone 24:305-313.
3. Armamento-Villareal R, Ziambaras K, Abbasi-Jarhomi SH, Dimarogonas A, Halstead L, Fausto A, Avioli LV, Civitelli R. 1997. An intact N terminus is required for the anabolic action of parathyroid hormone on adult female rats. J Bone Miner Res 12:384-392.
4. Bonewald LF, Dallas SL. 1994. Role of active and latent transforming growth factor beta in bone formation. J Cell Biochem 55:350-357.
5. Canalis E. 1996. Skeletal Growth Factors. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. San Diego: Academic Press, pp 261-279.
6. Chakravarthy BR, Durkin JP, Rixon RH, Whitfield JF. 1990. Parathyroid hormone fragment [3-34] stimulates protein kinase C (PKC) activity in rat osteosarcoma and murine T-lymphoma cells. Biochem Biophys Res Commun 171:1105-1110.
7. Cole JA, Carnes DL, Forte LR, Eber S, Poelling RE, Thorne PK. 1989. Structure-activity relationships of parathyroid hormone analogs in the opossum kidney cell line. J Bone Miner Res 4:723-730.
8. Davis VL, Couse JF, Gray TK, Korach KS. 1994. Correlation between low levels of estrogen receptors and estrogen responsiveness in two rat osteoblast-like cell lines. J Bone Miner Res 9:983-991.
9. Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R. 1993. Anabolic actions of parathyroid hormone on bone. Endocr Rev 14:690-709.
10. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M. 2000. Multiple actions of steroid hormones-A focus on rapid, nongenomic effects. Pharmacol Rev 52:513-556.
11. Farr D, Pochai W, Brown M, Shapiro E, Weinfeld N, Dziak R. 1984. Effects of prostaglandins on rat calvarial bone-cell calcium. Arch Oral Biol 29:885-891.
12. Fermor B, Skerry TM. 1995. PTH/PTHrP receptor expression on osteoblasts and osteocytes but not resorbing bone surfaces in growing rats. J Bone Miner Res 10:1935-1943.
13. Fujimori A, Cheng SL, Avioli LV, Civitelli R. 1992. Structure-function relationship of parathyroid hormone: Activation of phospholipase-C, protein kinase-A and -C in osteosarcoma cells. Endocrinology 130:29-36.
14. Fujita T, Meguro T, Fukuyama R, Nakamuta H, Koida M. 2002. New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells. Checkpoint of modulation by cyclic AMP. J Biol Chem 277:22191-22200.
15. Goltzman D. 1999. Interactions of PTH and PTHrP with the PTH/PTHrP receptor and with downstream signaling pathways: Exceptions that provide the rules. J Bone Miner Res 14:173-177.
16. Gray TK, Flynn TC, Gray KM, Nabell LM. 1987. 17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106. Proc Natl Acad Sci USA 84:6267-6271.
17. Habener JF, Rosenblatt M, Potts JT, Jr. 1984. Parathyroid hormone: Biochemical aspects of biosynthesis, secretion, action, and metabolism. Physiol Rev 64:985-1053.
18. Hall AK, Dickson IR. 1985. The effects of parathyroid hormone on osteoblast-like cells from embryonic chick calvaria. Acta Endocrinol (Copenh) 108:217-223.
19. Hilliker S, Wergedal JE, Gruber HE, Bettica P, Baylink DJ. 1996. Truncation of the amino terminus of PTH alters its anabolic activity on bone in vivo. Bone 19:469-477.
20. Hoare SR, Usdin TB. 2001. Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors. Curr Pharm Des 7:689-713.
21. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. 2000. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:2-12.
22. Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, Yamaguchi A. 1997. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 99; 2961-2970.
23. Isogai Y, Akatsu T, Ishizuya T, Yamaguchi A, Hori M, Takahashi N, Suda T. 1996. Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages. J Bone Miner Res 11:1384-1393.
24. Jilka RL, Weinstein RS, Beffido T, Roberson P, Parfitt AM, Manolagas SC. 1999. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439-446.
25. Jongen JW, Bos MP, van der Meer JM, Herrmann-Erlee MP. 1993. Parathyroid hormone-induced changes in alkaline phosphatase expression in fetal calvarial osteoblasts: Differences between rat and mouse. J Cell Physiol 155:36-43.
26. Juppner H. 1999. Receptors for parathyroid hormone and parathyroid hormone-related peptide: Exploration of their biological importance. Bone 25:87-90.
27. Kent GN, Loveridge N, Reeve J, Zanelli JM. 1985. Pharmacokinetics of synthetic human parathyroid hormone 1-34 in man measured by cytochemical bioassay and radioimmunoassay. Clin Sci (Lond) 68:171-177.
28. Lammi J, Huppunen J, Aarnisalo P. 2004. Regulation of the osteopontin gene by the orphan nuclear receptor NURR1 in osteoblasts. Mol Endocrinol 18:1546-1557.
29. Liang P, Zhu W, Zhang X, Guo Z, O'Connell RP, Averboukh L, Wang F, Pardee AB. 1994. Differential display using one-base anchored oligo-dT primers. Nucleic Acids Res 22:5763-5764.
30. Ma YL, Cain RL, Halladay DL, Yang X, Zeng Q, Miles RR, Chandrasekhar S, Martin TJ, Onyia JE. 2001. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 142:4047-4054.
31. Manolagas SC. 2000. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21:115-137.
32. Mohan S, Kutilek S, Zhang C, Shen HG, Kodama Y, Srivastava AK, Wergedal JE, Beamer WG, Baylink DJ. 2000. Comparison of bone formation responses to parathyroid hormone(1-34), (1-31), and (2-34) in mice. Bone 27:471-478.
33. Onyia JE, Helvering LM, Gelbert L, Wei T, Huang S, Chen P, Dow ER, Maran A, Zhang M, Lotinun S, Lin X, Halladay DL, Miles RR, Kulkarni NH, Ambrose EM, Ma YL, Frolik CA, Sato M, Bryant HU, Turner RT. 2005. Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: An analysis by DNA microarray. J Cell Biochem 95:403-418.
34. Papapoulos SE, Manning RM, Hendy GN, Lewin IG, O'Riordan JL. 1980. Studies of circulating parathyroid hormone in man using a homologous amino-terminal specific immunoradiometric assay. Clin Endocrinol (Oxf) 13:57-67.
35. Partridge NC, Alcorn D, Michelangeli VP, Kemp BE, Ryan GB, Martin TJ. 1981. Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells. Endocrinology 108:213-219.
36. Podbesek R, Edouard C, Meunier PJ, Parsons JA, Reeve J, Stevenson RW, Zanelli JM. 1983. Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology 112:1000-1006.
37. Qin L, Qiu P, Wang L, Li X, Swarthout JT, Soteropoulos P, Tolias P, Partridge NC. 2003. Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics. J Biol Chem 278:19723-19731.
38. Qin L, Raggatt LJ, Partridge NC. 2004. Parathyroid hormone: A double-edged sword for bone metabolism. Trends Endocrinol Metab 15:60-65.
39. Raisz LG, Martin TJ. 1984. Prostaglandins in bone and mineral metabolism. In: Peck WA, editor. Bone and mineral research annual. Amsterdam: Elsevier, pp 286-310.
40. Riggs BL, Melton LJ, III. 1986. Involutional osteoporosis. N Engl J Med 314:1676-1686.
41. Rixon RH, Whitfield JF, Gagnon L, Isaacs RJ, Maclean S, Chakravarthy B, Durkin JP, Neugebauer W, Ross V, Sung W, et al. 1994. Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase. J Bone Miner Res 9:1179-1189.
42. Robinson JA, Susulie V, Zhao W, Khorde Y, Gironda V, Liu YB, Wasko M, Murrills R, Bex F. 2003. PTH Anabolic Induced Gene in Bone (PAIGB), a Novel geve which may play an important role in bone formation. J Bone Miner Res 18:5174.
43. Rodan GA. 1996. Coupling of bone resorption and formation during bone remodeling. In: Marcus R, Feldman D, Delsey J, editors. Osteoporosis. San Diego: Academic Press, pp 289-299.
44. Rosen V, Cox K, Hattersley G. 1996. Bone morphogenetic proteins. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. San Diego: Academic Press, pp 661-671.
45. Sampath D, Zhu Y, Winneker RC, Zhang Z. 2001. Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/ Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas. J Clin Endocrinol Metab 86:1707-1715.
46. Schiller PC, D'Ippolito G, Roos BA, Howard GA. 1999. Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment. J Bone Miner Res 14:1504-1512.
47. Swarthout JT, Doggett TA, Lemker JL, Partridge NC. 2001. Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C-dependent. J Biol Chem 276:7586-7592.
48. Swarthout JT, D'Alonzo RC, Selvamurugan N, Partridge NC. 2002. Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene 282:1-17.
49. Tam CS, Heersche JN, Murray TM, Parsons JA. 1982. Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: Differential effects of intermittent and continuous administration. Endocrinology 110:506-512.
50. Tanner SM, Austin JL, Leone G, Rush LJ, Plass C, Heinonen K, Mrozek K, Sill H, Knuutila S, Kolitz JE, Archer KJ, Caligiuri MA, Bloomfield CD, de La Chapelle A. 2001. BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proc Natl Acad Sci USA 98:13901-13906.
51. Tashjian AH, Jr., Chabner BA. 2002. Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal women. J Bone Miner Res 17:1151-1161.
52. Urena P, Kong XF, Abou-Samra AB, Juppner H, Kronenberg HM, Potts JT, Jr., Segre GV. 1993. Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology 133:617-623.
53. Wang X, Tian QB, Okano A, Sakagami H, Moon IS, Kondo H, Endo S, Suzuki T. 2005. BAALC 1-6-8 protein is targeted to postsynaptic lipid rafts by its N-terminal myristoylation and palmitoylation, and interacts with alpha, but not beta, subunit of Ca/calmodulin-dependent protein kinase II. J Neurochem 92:647-659.
54. Whitfield JF, Morley P, Willick GE, Ross V, Barbier JR, Isaacs RJ, Ohannessian-Barry L. 1996. Stimulation of the growth of femoral trabecular bone in ovariectomized rats by the novel parathyroid hormone fragment, hPTH-(1-31)NH2 (Ostabolin). Calcif Tissue Int 58:81-87.
55. Whitfield JF, Morley P, Willick GE. 1999. The bone-building action of the parathyroid hormone: Implications for the treatment of osteoporosis. Drugs Aging 15:117-129.
56. Yamaguchi DT, Green J, Merritt BS, Kleeman CR, Muallem S. 1989. Modulation of osteoblast function by prostaglandins. Am J Physiol 257:F755-F761.
57. Zanello LP, Norman AW. 1997. Stimulation by 1alpha,25(OH)2-vitamin D3 of whole cell chloride currents in osteoblastic ROS 17/2.8 cells. A structure-function study. J Biol Chem 272:22617-22622.
58. Zanello LP, Norman AW. 2004. Rapid modulation of osteoblast ion channel responses by lalpha,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. Proc Natl Acad Sci USA 101:1589-1594.
59. Zhao W, Murrilla R, Tarby M, Dell V, Kharode Y, Bex F. 2001. Local anabolic effects of parathyroid hormone in a mouse calvarial model. J Bone Miner Res 16:S306.